Bafna Pharmaceuticals Ltd.
Snapshot View

100.00 +0.90 ▲0.9%

29 September 2022, 01:06:28 PM
Volume: 2,467

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bafnapharma.com
Market Cap 243.07 Cr.
Enterprise Value(EV) 252.29 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.87 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 54.92 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 27.16 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.78 Calculated using Price: 102.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.37 Cr. 23,656,335 Shares
FaceValue 10
Company Profile
Bafna Pharmaceuticals was incepted by Bafna Mahaveer Chand in 1981 as a proprietary concern. It was converted into a public limited company on 28th march 1995. The company started its own manufacturing unit in October 1984.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.91%
1 Week
-2.63%
1 Month
-13.01%
3 Month
-14.20%
6 Month
-21.35%
1 Year
-22.30%
2 Year
+151.26%
5 Year
+288.35%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.25 9.22 -18.69 -37.05 -40.37 -64.36 -22.93 22.26 8.61
Return on Capital Employed (%) 9.15 12.56 -0.04 -5.98 -6.97 -20.90 -2.95 10.62 8.39
Return on Assets (%) 0.57 2.99 -6.58 -10.49 -11.17 -15.90 -1.96 7.40 5.83

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 67 69 72 59 45 41 21 51 57 63
Non Curr. Liab. 29 27 14 39 42 28 29 3 5 11
Curr. Liab. 147 126 100 87 81 59 71 17 24 16
Minority Int.
Equity & Liab. 243 223 185 185 167 128 121 71 86 90
Non Curr. Assets 69 66 68 65 90 79 72 35 37 39
Curr. Assets 167 149 117 119 77 48 48 36 50 51
Misc. Exp. not W/O 6 8 1
Total Assets 243 223 185 185 167 128 121 71 86 90

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 178 143 85 65 47 44 42 71 85 81
Other Income 1 1 1 1 31 0 0 1 2 3
Total Income 179 144 87 66 78 44 43 72 87 84
Total Expenditure -156 -117 -83 -70 -82 -57 -41 -61 -74 -71
PBIDT 23 26 4 -4 -4 -13 1 11 14 13
Interest -12 -12 -12 -11 -7 -2 0 -1 -1 -1
Depreciation -8 -5 -4 -4 -4 -3 -3 -4 -5 -5
Taxation -1 0 0 1 -2 -2
Exceptional Items -3 -2 -2
PAT 1 6 -12 -18 -16 -20 -2 6 5 4
Adjusted EPS 1 3 -7 -10 -7 -8 -8 2 2 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 35 1 9 -3 20 -7 -1 -34 -14 8
Cash Fr. Inv. -6 -5 56 -1 -14 38 4 33 -5 -5
Cash Fr. Finan. -11 -14 -66 4 -5 -31 -2 7 12 -4
Net Change 18 -18 0 0 0 0 6 -7 -2
Cash & Cash Eqvt 21 2 2 3 3 3 3 8 2 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 26.40 92.64 92.64 91.74 90.39 90.40 90.42 90.42 90.12
Public 73.60 7.36 7.36 8.26 9.61 9.60 9.58 9.58 9.88
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 50.96 1.45 1.45 1.47 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 28 Sep 2022
General updates
Bafna Pharmaceuticals Limited has informed the Exchange about Sale Of Equity Shares Of The Company By SRJR Life Science LLP Through Open Market Sale For acheiving Minimum Public Shareholding.
Fri, 12 Aug 2022
Outcome of Board Meeting
Bafna Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider and approve unaudited financial results for the quarter ended 30th June 2022 along with limited review report
Fri, 12 Aug 2022
Resignation
Bafna Pharmaceuticals Limited has informed the Exchange about resignation of ROOPA RAVIKUMAR as Company Secretary and compliance officer of the company w.e.f. 11-Aug-2022

Technical Scans View Details >>

Wed, 28 Sep 2022
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 930.65 +1.4%
Divi's Laboratories Ltd. 98,114.53 3,708.95 +0.2%
Cipla Ltd. 88,495.80 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. 50,536.67 1,538.30 +2.9%
Alkem Laboratories Ltd. 39,477.37 3,194.20 -3.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-06 35.56 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,194.20 -3.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-06 4.12 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,194.20 -3.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,194.20 -3.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,194.20 -3.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,194.20 -3.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,194.20 -3.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 930.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,194.20 -3.1%

FAQ's On Bafna Pharmaceuticals Ltd.

What is Bafna Pharma share price?

Can I buy Bafna Pharma shares now?

What is the Market Cap of Bafna Pharma?

What are the key metrics to analyse Bafna Pharma?

What is the 52 Week High and Low of Bafna Pharma?

What is the trend of Bafna Pharma share price?